China Health Group (HKSE:00673) EBIT : HK$-26.85 Mil (TTM As of Sep. 2023)

View and export this data going back to 1996. Start your Free Trial

What is China Health Group EBIT?

China Health Group's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2023 was HK$-16.36 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.85 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Health Group's annualized ROC % for the quarter that ended in Sep. 2023 was -17.11%. China Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -138.70%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Health Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -5.74%.

China Health Group EBIT Historical Data

The historical data trend for China Health Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Group EBIT Chart

China Health Group Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

-19.93

-34.19

-5.04

-8.42

-37.19

China Health Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT	Get a 7-Day Free Trial															-4.54	-3.88	-26.70	-10.49	-16.36

Competitive Comparison of China Health Group's EBIT

For the Medical Distribution subindustry, China Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Group's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Health Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Health Group's EV-to-EBIT falls into.

China Health Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-26.85 Mil.

China Health Group (HKSE:00673) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Health Group's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	-31.616 * ( 1 - -0.34% )	/	( (124.65	+	246.181)	/ 2 )
=	-31.7234944	/	185.4155
=	-17.11 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	221.185	-	85.055	-	( 11.48	-	max(0, 127.235	-	142.135	+	11.48	))
=	124.65

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	367.354	-	118.357	-	( 3.255	-	max(0, 133.854	-	136.67	+	3.255	))
=	246.181

Note: The Operating Income data used here is two times the semi-annual (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

China Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-32.722	/	( ( (24.038 + max(-56.735, 0))	+	(23.146 + max(-85.352, 0)) )	/	2 )
=	-32.722	/	( ( 24.038	+	23.146 )	/	2 )
=	-32.722	/	23.592
=	-138.70 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(30.751	+	11.666	+	22.046)	-	(85.055	+	0	+	36.143)
=	-56.735

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(27.715	+	14.117	+	0)	-	(118.357	+	0	+	8.827)
=	-85.352

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Health Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2023 )
	=	-26.854	/	468.040
	=	-5.74 %

China Health Group EBIT Related Terms

Thank you for viewing the detailed overview of China Health Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Group (HKSE:00673) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Health Group Ltd (HKSE:00673) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

141 Des Voeux Road, Unit 801, 8th Floor, China Insurance Group Building, Central, Hong Kong, HKG

Website

http://www.ch-groups.com

China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management service, and business factoring. It operates in the business in three segments Distribution and service in medical equipment and consumables; Hospital operation and management services and Business factoring service. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically the group's locations are located in the PRC.

Executives

Treasure Wagon Limited	2101 Beneficial owner
Zhang Fan	2201 Interest of corporation controlled by you
Best Robust Ventures Limited	2101 Beneficial owner
Sun Chunlei	2201 Interest of corporation controlled by you
Yang Huijun	2201 Interest of corporation controlled by you
Chg Victory Limited	2301 Trustee
Coral Point Global Limited	2101 Beneficial owner
Ye Zhankun	2201 Interest of corporation controlled by you

China Health Group (HKSE:00673) Headlines

No Headlines